{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:26:15Z","timestamp":1791465975521,"version":"4.3.4"},"reference-count":69,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003390","name":"Fritz Thyssen Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,7,28]]},"abstract":"<jats:p>Despite the remarkable successes of cancer immunotherapies, the majority of patients will experience only partial response followed by relapse of resistant tumors. While treatment resistance has frequently been attributed to clonal selection and immunoediting, comparisons of paired primary and relapsed tumors in melanoma and breast cancers indicate that they share the majority of clones. Here, we demonstrate in both mouse models and clinical human samples that tumor cells evade immunotherapy by generating unique transient cell-in-cell structures, which are resistant to killing by T cells and chemotherapies. While the outer cells in this cell-in-cell formation are often killed by reactive T cells, the inner cells remain intact and disseminate into single tumor cells once T cells are no longer present. This formation is mediated predominantly by IFN\u03b3-activated T cells, which subsequently induce phosphorylation of the transcription factors signal transducer and activator of transcription 3 (STAT3) and early growth response-1 (EGR-1) in tumor cells. Indeed, inhibiting these factors prior to immunotherapy significantly improves its therapeutic efficacy. Overall, this work highlights a currently insurmountable limitation of immunotherapy and reveals a previously unknown resistance mechanism which enables tumor cells to survive immune-mediated killing without altering their immunogenicity.<\/jats:p>","DOI":"10.7554\/elife.80315","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T04:15:13Z","timestamp":1659068113000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.80315","source":"Crossref","is-referenced-by-count":55,"title":["Transient cell-in-cell formation underlies tumor relapse and resistance to immunotherapy"],"prefix":"10.7554","volume":"11","author":[{"given":"Amit","family":"Gutwillig","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Santana-Magal","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Farhat-Younis","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Rasoulouniriana","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3441-3228","authenticated-orcid":true,"given":"Asaf","family":"Madi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Luxenburg","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cohen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnanand","family":"Padmanabhan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Shomron","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9376-4955","authenticated-orcid":true,"given":"Guy","family":"Shapira","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-4224","authenticated-orcid":true,"given":"Annette","family":"Gleiberman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Parikh","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmit","family":"Levy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meora","family":"Feinmesser","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]},{"id":[{"id":"https:\/\/ror.org\/01vjtf564","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Pathology, Rabin Medical Center- Beilinson Hospital","place":["Petach Tikva, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Hershkovitz","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]},{"id":[{"id":"https:\/\/ror.org\/04nd58p63","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Pathology, Tel Aviv Sourasky Medical Center","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Zemser-Werner","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04nd58p63","id-type":"ROR","asserted-by":"publisher"}],"name":"Institute of Pathology, Tel Aviv Sourasky Medical Center","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oran","family":"Zlotnik","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01vjtf564","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of General Surgery, Rabin Medical Center- Beilinson Campus","place":["Petach Tikva, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5722-0763","authenticated-orcid":true,"given":"Sanne","family":"Kroon","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02p1jz666","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biology, Institute of Microbiology","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9892-6420","authenticated-orcid":true,"given":"Wolf-Dietrich","family":"Hardt","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02p1jz666","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Biology, Institute of Microbiology","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3649-807X","authenticated-orcid":true,"given":"Reno","family":"Debets","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03r4m3349","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Oncology, Erasmus MC Cancer Institute","place":["Rotterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan Edward","family":"Reticker-Flynn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00f54p054","id-type":"ROR","asserted-by":"publisher"}],"name":"School of Medicine, Department of Pathology, Stanford University","place":["Stanford, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peleg","family":"Rider","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-0616","authenticated-orcid":true,"given":"Yaron","family":"Carmi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Sackler School of Medicine, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s43018-020-00136-x","article-title":"Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity","volume":"2","author":"Ackerman","year":"2021","journal-title":"Nature Cancer"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/2159-8290.CD-16-0828","article-title":"Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Anagnostou","year":"2017","journal-title":"Cancer Discovery"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/annonc\/mdv209","article-title":"Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?","volume":"26","author":"Apetoh","year":"2015","journal-title":"Annals of Oncology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1126\/science.aay9207","article-title":"Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells","volume":"368","author":"B\u00e1lint","year":"2020","journal-title":"Science"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nm.2128","article-title":"Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy","volume":"16","author":"Bendle","year":"2010","journal-title":"Nature Medicine"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00262-017-2001-3","article-title":"MuPeXI: prediction of neo-epitopes from tumor sequencing data","volume":"66","author":"Bjerregaard","year":"2017","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nature Biotechnology"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature14424","article-title":"Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity","volume":"521","author":"Carmi","year":"2015","journal-title":"Nature"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1074\/mcp.M600365-MCP200","article-title":"Organelle proteomics: identification of the exocytic machinery associated with the natural killer cell secretory lysosome","volume":"6","author":"Casey","year":"2007","journal-title":"Molecular & Cellular Proteomics"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nature Medicine"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nature Immunology"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"DuPage","year":"2012","journal-title":"Nature"},{"key":"bib15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.27134","article-title":"Mitosis can drive cell cannibalism through entosis","volume":"6","author":"Durgan","year":"2017","journal-title":"eLife"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.immuni.2019.12.010","article-title":"Human anti-tumor immunity: Insights from immunotherapy clinical trials","volume":"52","author":"Egen","year":"2020","journal-title":"Immunity"},{"key":"bib17","doi-asserted-by":"publisher","DOI":"10.1002\/9780471729259.mc02b02s25","article-title":"Scanning electron microscopy","volume":"Chapter 2","author":"Fischer","year":"2012","journal-title":"Current Protocols in Microbiology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nature Reviews. Cancer"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nature Immunology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1158\/1078-0432.CCR-18-0793","article-title":"Long-term survival in patients responding to anti-pd-1\/pd-l1 therapy and disease outcome upon treatment discontinuation","volume":"25","author":"Gauci","year":"2019","journal-title":"Clinical Cancer Research"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","article-title":"Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma","volume":"24","author":"Gide","year":"2018","journal-title":"Clinical Cancer Research"},{"key":"bib23","first-page":"127","article-title":"Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity","volume":"21","author":"Gross","year":"1989","journal-title":"Transplantation Proceedings"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature14347","article-title":"The evolutionary history of lethal metastatic prostate cancer","volume":"520","author":"Gundem","year":"2015","journal-title":"Nature"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/0973-029X.203763","article-title":"Emperipolesis, entosis and cell cannibalism: Demystifying the cloud","volume":"21","author":"Gupta","year":"2017","journal-title":"Journal of Oral and Maxillofacial Pathology"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.celrep.2017.06.037","article-title":"Entosis is induced by glucose starvation","volume":"20","author":"Hamann","year":"2017","journal-title":"Cell Reports"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/ng.3683","article-title":"Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma","volume":"48","author":"Hao","year":"2016","journal-title":"Nature Genetics"},{"key":"bib28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of us patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Network Open"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"PNAS"},{"key":"bib31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Science Translational Medicine"},{"key":"bib32","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.06.47","article-title":"The combination of checkpoint immunotherapy and targeted therapy in cancer","volume":"5","author":"Karachaliou","year":"2017","journal-title":"Annals of Translational Medicine"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/ni1102-999","article-title":"Natural selection of tumor variants in the generation of \u201ctumor escape\u201d phenotypes","volume":"3","author":"Khong","year":"2002","journal-title":"Nature Immunology"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.6925.1","article-title":"Gosummaries: An r package for visual functional annotation of experimental data","volume":"4","author":"Kolde","year":"2015","journal-title":"F1000Research"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s00018-016-2207-0","article-title":"Mechanisms and consequences of entosis","volume":"73","author":"Krishna","year":"2016","journal-title":"Cellular and Molecular Life Sciences"},{"key":"bib36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biology"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"Matsushita","year":"2012","journal-title":"Nature"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","article-title":"New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape","volume":"27","author":"Mittal","year":"2014","journal-title":"Current Opinion in Immunology"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.cell.2007.10.040","article-title":"A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion","volume":"131","author":"Overholtzer","year":"2007","journal-title":"Cell"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: induction of \u201cself\u201d-reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"The Journal of Experimental Medicine"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nature Reviews. Cancer"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of pten promotes resistance to t cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discovery"},{"key":"bib44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00784","article-title":"The tumor microenvironment in the response to immune checkpoint blockade therapies","volume":"11","author":"Petitprez","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nature Reviews. Immunology"},{"key":"bib46","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0391-1","article-title":"Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option","volume":"6","author":"Rohaan","year":"2018","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrclinonc.2014.174","article-title":"Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment","volume":"11","author":"Rosenberg","year":"2014","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"bib48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nature Communications"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.21037\/tlcr.2018.01.14","article-title":"Nivolumab in pretreated non-small cell lung cancer: continuing the immunolution","volume":"7","author":"Salati","year":"2018","journal-title":"Translational Lung Cancer Research"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1158\/0008-5472.CAN-19-2944","article-title":"Melanoma-secreted lysosomes trigger monocyte-derived dendritic cell apoptosis and limit cancer immunotherapy","volume":"80","author":"Santana-Magal","year":"2020","journal-title":"Cancer Research"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/14712598.2019.1571036","article-title":"Immunotherapy alone or chemo-immunotherapy as front-line treatment for advanced non-small cell lung cancer","volume":"19","author":"Shafique","year":"2019","journal-title":"Expert Opinion on Biological Therapy"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/mt.2014.215","article-title":"Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment","volume":"23","author":"Straetemans","year":"2015","journal-title":"Molecular Therapy"},{"key":"bib56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00233","article-title":"Combination approaches with immune-checkpoint blockade in cancer therapy","volume":"6","author":"Swart","year":"2016","journal-title":"Frontiers in Oncology"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1083\/jcb.201904051","article-title":"Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival","volume":"218","author":"Tonnessen-Murray","year":"2019","journal-title":"The Journal of Cell Biology"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-cell transfer therapy targeting mutant kras in cancer","volume":"375","author":"Tran","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature18945","article-title":"Neoantigen landscape dynamics during human melanoma-T cell interactions","volume":"536","author":"Verdegaal","year":"2016","journal-title":"Nature"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"bib63","article-title":"NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma","volume":"13","author":"von Boehmer","year":"2013","journal-title":"Cancer Immunity"},{"key":"bib64","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00311","article-title":"Cell-in-cell phenomenon and its relationship with tumor microenvironment and tumor progression: A review","volume":"7","author":"Wang","year":"2019","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","article-title":"Genomic evolution of breast cancer metastasis and relapse","volume":"32","author":"Yates","year":"2017","journal-title":"Cancer Cell"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nature Medicine"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1126\/science.1068539","article-title":"Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells","volume":"296","author":"Zacharias","year":"2002","journal-title":"Science"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to pd-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"The New England Journal of Medicine"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/80315\/elife-80315-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/80315\/elife-80315-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/80315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:23:52Z","timestamp":1697059432000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/80315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":69,"alternative-id":["10.7554\/eLife.80315"],"URL":"https:\/\/doi.org\/10.7554\/elife.80315","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.10.287441","asserted-by":"subject"}],"is-supplemented-by":[{"id-type":"accession","id":"GSE164076","asserted-by":"subject"},{"id-type":"accession","id":"GSE164075","asserted-by":"subject"},{"id-type":"accession","id":"GSE164077","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.742328306.793596308","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.80315.sa0","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.80315.sa1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.80315.sa2","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e80315"}}